Xtl Biopharmaceuticals (XTLB) Goodwill & Intangibles (2010 - 2024)
Xtl Biopharmaceuticals (XTLB) posted quarterly Goodwill & Intangibles of $7.0 million for Q4 2024, up 1744.47% year-on-year from $380000.0 in Q1 2024, and down 0.95% on a QoQ basis from $7.1 million in Q3 2024.
Xtl Biopharmaceuticals (XTLB) Goodwill & Intangibles (2010 - 2024) Analysis & Trends
Xtl Biopharmaceuticals (XTLB) has reported Goodwill & Intangibles for 15 consecutive years, with $7.0 million the latest figure, recorded in Q4 2024.
- Quarterly Goodwill & Intangibles rose 1744.47% year-over-year to $7.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $7.0 million (up 1744.47% YoY) and the FY2024 annual result came in at $7.0 million, up 1744.47% from the prior year.
- Goodwill & Intangibles slipped to $7.0 million in Q4 2024 per XTLB's latest filing, from $7.1 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for XTLB reached as high as $7.1 million in Q3 2024 and fell as low as $380000.0 in Q4 2020.
- A 5-year average of $1.3 million and a median of $380000.0 in 2020 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2020 — Goodwill & Intangibles changed 0.0% — and 2024, when it jumped 1762.11%.
- Year by year, Goodwill & Intangibles stood at $380000.0 in 2020, then changed by 0.0% to $380000.0 in 2021, then changed by 0.0% to $380000.0 in 2022, then changed by 0.0% to $380000.0 in 2023, then soared by 1744.47% to $7.0 million in 2024.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $7.0 million, $7.1 million, and $380000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 7.01 Mn |
| Sep 30, 2024 | 7.08 Mn |
| Jun 30, 2024 | 380,000.00 |
| Mar 31, 2024 | 380,000.00 |
| Dec 31, 2023 | 380,000.00 |
| Sep 30, 2023 | 380,000.00 |
| Jun 30, 2023 | 380,000.00 |
| Mar 31, 2023 | 380,000.00 |
| Dec 31, 2022 | 380,000.00 |
| Sep 30, 2022 | 380,000.00 |
| Jun 30, 2022 | 380,000.00 |
| Dec 31, 2021 | 380,000.00 |
| Jun 30, 2021 | 380,000.00 |
| Dec 31, 2020 | 380,000.00 |
| Dec 31, 2019 | 380,000.00 |
| Dec 31, 2018 | 380,000.00 |
| Sep 30, 2018 | 380,000.00 |
| Dec 31, 2017 | 380,000.00 |
| Dec 31, 2016 | 253,000.00 |
| Jun 30, 2016 | 1.10 Mn |